Company profile

MIRA PHARMACEUTICALS, INC. CIK 1904286

Ticker

MIRA (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Miami, FL 33131

Fiscal year end

2025 (FY)

Market Data

$0.68

Change

-$0.04

Change %

-4.90%

Volume

101

MIRA · trading date Oct 8, 2026 · previous close $0.72 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials

Revenue

—

Net income

-$10.44M

Total assets

$11.09M

Total liabilities

$702.1K

Stockholders' equity

$10.39M

Cash & equivalents

$6.35M

Operating income

—

Operating cash flow

-$4.66M

Capital expenditures

—

Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance

Operating margin

—

Net margin

—

Free cash flow

—

Free cash flow margin

—

Liabilities / assets

6.3%

Equity / assets

93.7%

CapEx / revenue

—

Operating cash flow / net income

0.45×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History

Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity

2025 — -$10.44M $11.09M $702.1K $10.39M

2024 — -$7.85M $2.92M $723.3K $2.20M

2023 — -$11.98M $4.93M $558.1K $4.37M

2022 — -$7.06M $858.1K $1.45M -$596.2K

Company Details

SIC code

2834

State of incorporation

Active filer

Yes

Most recent SEC filing

Form 8-K

2026-09-17

Financials filed via

Form 10-K

filed 2026-03-31

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location

Miami, FL 33131

1200 BRICKELL AVENUE

Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:27 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Florida — Public Companies